Redeye retains its positive view of CombinedX following a relatively soft Q2.
Q2 details Lower sales and earnings vs. consensus. Sales came in at SEK 1,610m (-4% vs.
Redeye comments on Absolent’s Q2 numbers which overall were a notch below our forecast.
Redeye states that Eniro’s Q2 2025 report was slightly weaker across all items.
Redeye is encouraged to see Tagmaster’s Q2 report beating our estimates by a wide margin.
Redeye provides an initial comment on the Q2 2025 report from Tradedoubler, which showed solid growt...
Q2 details Sales SEK 427m (5% vs ABG 408m, -1% vs cons 421m).
Redeye comments on Invisio’s Q2-results which saw stronger-than-expected revenue while EBITDA was lo...
Q2'25 outcome The Q2 report was above consensus' expectations.
Oriola posted strong growth figures in Q2, with net sales up 12% y/y and both segments showing doubl...
Redeye provides its initial take on Lagercrantz’s Q1 2025/2026 report, which came in slightly below ...
Redeye provides its first take on Cellavision’s Q2 report 2025, published this morning.
Redeye comments on Annexin’s Q2 report and recent events in the company.
Q2 in brief: better overall Our impression is that Svedbergs Group's Q2 report is better than Factse...
Redeye provides a short comment on the Q2 2025 report from Sdiptech, which came in below our estimat...
